Literature DB >> 30955916

Analysis of Vascular Event Risk After Herpes Zoster From 2007 to 2014 US Insurance Claims Data.

Brandon J Patterson1, Debora A Rausch2, Debra E Irwin3, Michael Liang4, Songkai Yan5, Barbara P Yawn6.   

Abstract

OBJECTIVE: To estimate the risk of transient ischemic attack (TIA), stroke, and myocardial infarction in periods covering 4 weeks before to 52 weeks after herpes zoster (HZ) diagnosis in US adults. PATIENTS AND METHODS: This retrospective study (GSK study identifier: HO-15-15771) with matched cohorts used the Truven Health MarketScan Commercial and Medicare claims data set linked with obesity and smoking status information. Patients 18 years and older at the date of HZ diagnosis and 1-year pre- and post-HZ diagnosis continuous insurance enrollment (from January 1, 2007, through December 31, 2014) were propensity score matched to controls in terms of demographic characteristics, risk factors for vascular events, other comorbid disorders, general health, obesity, and smoking status. A post hoc sensitivity analysis was performed not matching for obesity and smoking status information. Adjusted incidence rate ratios (IRRs) were estimated using multivariate Poisson models during an aggregate period (1-month before and after the index date).
RESULTS: A total of 23,339 patients with HZ were matched to 46,378 controls (mean age, 56 years; 45,173 [65%] women). During the aggregate period, patients with HZ were statistically significantly more likely to suffer a TIA: IRRs for all patients and patients aged 18 to 49 years were 1.56 (95% confidence interval [CI], 1.13-2.15) and 5.12 (95% CI, 1.37-19.10), respectively (P<.05); the respective IRRs for stroke were 1.40 (95% CI, 0.93-2.11) and 8.12 (95% CI, 0.93-71.27). In the sensitivity analysis, IRRs for TIA and stroke were statistically significantly increased regardless of age.
CONCLUSION: Herpes zoster was associated with an increased risk of composite events, TIA, and stroke in adults in the period around diagnosis. More research on the HZ and vascular risk association is needed. GSK STUDY IDENTIFIER: HO-15-15771.
Copyright © 2019 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30955916     DOI: 10.1016/j.mayocp.2018.12.025

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  8 in total

1.  Increased Health Care Resource Utilization and Costs Associated with Herpes Zoster Among Patients Aged ≥50 Years with Chronic Obstructive Pulmonary Disease in the United States.

Authors:  Parinaz Ghaswalla; Philippe Thompson-Leduc; Wendy Y Cheng; Colin Kunzweiler; Min-Jung Wang; Michael Bogart; Brandon J Patterson; Mei Sheng Duh; John Wojciehowski; Suna Park; Barbara P Yawn
Journal:  Chronic Obstr Pulm Dis       Date:  2021-10-28

2.  Herpes Zoster, a Rash of Cerebrovascular Events.

Authors:  Maria A Nagel; Andrew N Bubak
Journal:  Mayo Clin Proc       Date:  2019-05       Impact factor: 7.616

Review 3.  Adult preventive vaccines with other synergistic lifestyle options: is it time to add these ancillary benefits to the overall AS management checklist?

Authors:  Mark A Moyad
Journal:  World J Urol       Date:  2021-05-07       Impact factor: 4.226

4.  Disseminated herpes zoster with acute encephalitis in an immunocompetent elderly man.

Authors:  Jessica Hyejin Oh; Saketh Tummala; Muhammad Ghazanfar Husnain
Journal:  BMJ Case Rep       Date:  2020-06-24

5.  Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: A self-controlled case series and nested case-control study.

Authors:  Eric Yuk Fai Wan; Celine Sze Ling Chui; Yuan Wang; Vanessa Wai Sei Ng; Vincent Ka Chun Yan; Francisco Tsz Tsun Lai; Xue Li; Carlos King Ho Wong; Esther Wai Yin Chan; Christina Sze Man Wong; Kathy Sze Man Leung; Michael Yuxuan Ni; Sophie Alessandra Valkenburg; Joseph Sriyal Malik Peiris; Joseph Tsz Kei Wu; Benjamin John Cowling; Darren M Ashcroft; Ivan Fan Ngai Hung; Gabriel Matthew Leung; Ian Chi Kei Wong
Journal:  Lancet Reg Health West Pac       Date:  2022-02-02

6.  Short-Term Prognostic Factors in Hospitalized Herpes Zoster Patients and Its Associated Cerebro-Cardiovascular Events: A Nationwide Retrospective Cohort in Japan.

Authors:  Yuichi Ishikawa; Kazuhisa Nakano; Kei Tokutsu; Shingo Nakayamada; Shinya Matsuda; Kiyohide Fushimi; Yoshiya Tanaka
Journal:  Front Med (Lausanne)       Date:  2022-03-04

7.  Estimated Public Health Impact of the Recombinant Zoster Vaccine.

Authors:  Brandon J Patterson; Philip O Buck; Desmond Curran; Desirée Van Oorschot; Justin Carrico; William L Herring; Yuanhui Zhang; Jeffrey J Stoddard
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-05-26

Review 8.  Vaccination in Older Adults: An Underutilized Opportunity to Promote Healthy Aging in India.

Authors:  Agam Vora; Alberta Di Pasquale; Shafi Kolhapure; Ashish Agrawal
Journal:  Drugs Aging       Date:  2021-06-14       Impact factor: 3.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.